Yuji Mukai

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Simultaneous Determination

Tyrosine Kinase

Epidermal Growth Factor Receptor

Acute Lymphoblastic Leukemia

Top Venues

British journal of clinical pharmacology

Biomedical chromatography : BMC

Therapeutic drug monitoring

This page only lists publications with an associated author ORCID identifier.

Publications

Yuka Aida, Masahiro Ohgami, Yuji Mukai, Masashi Matsuyama, Mana Obata-Yasuoka, Toyomi Satoh, Masato Homma, Ikuo Sekine, Nobuyuki Hizawa
Pharmacokinetic study of erlotinib in a pregnant woman with advanced non-small cell lung cancer and observation of the effects on the child growth. British journal of clinical pharmacology (2024)
Yuji Mukai, Narushi Sugii, Kosuke Doki, Masato Homma
An analytical method using salting-out assisted liquid-liquid extraction to quantify ceftriaxone from micro volumes of human serum. Biomedical chromatography : BMC (2024)
Yuji Mukai, Narushi Sugii, Kosuke Doki, Masato Homma
An analytical method using salting-out assisted liquid-liquid extraction to quantify ceftriaxone from micro volumes of human serum. Biomedical chromatography : BMC 38 (9) (2024)
Yuji Mukai, Kosuke Doki, Yoshiharu Suzuki, Masato Homma
Utilizing the dry spot method to monitor the concentrations of biologic agents in breast milk. British journal of clinical pharmacology (2023)
Yuji Mukai, Tatsunari Yoshida, Takeshi Kondo, Jun Miura, Nobuo Inotsume, Takaki Toda
Development and Validation of a Simple Method for Simultaneously Measuring the Concentrations of BCR-ABL and Bruton Tyrosine Kinase Inhibitors in Dried Blood Spot (DBS): A Pilot Study to Obtain Candidate Conversion Equations for Predicting Plasma Concentration Based on DBS Concentration. Therapeutic drug monitoring 44 (6) (2022)